MASLD: Prognosis and treatments MASLD, formerly referred to as nonalcoholic fatty liver disease, represents a significant global health burden, with rising prevalence and associated risks of fibrosis, cirrhosis, and mortality
That's a genuinely significant development in obesity medicine, and it's the reason GLP-1 therapy has moved from "cosmetic weight loss medication" to "cardiometabolic treatment" in clinical guidelines
Patients should contact their plan provider because benefits and requirements vary
Chronic depression, obesity, terrible sleep, raising 3 kids, startup founder/CEO grind culture behavior (and even growing up w/ excess sugar, sun exposure, junk food). Its worth remembering: Zero (@bryan_johnson) July 18, 2023 1) My body and mind were trashed in every way for 23 years